Temperature-Stable TB Vaccine Safe, Promp ts Immune Response in NIH-Supported Study

Laden...

1 jaar geleden

Html
Tekst

Having trouble viewing this email? View it as a Web page.

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

Temperature-Stable TB Vaccine Safe, Prompts Immune Response in NIH-Supported Study 03/06/2023 10:00 AM EST
Freeze-dried experimental TB vaccine tested in healthy adults.

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website.

This service is provided to you by the National Institutes of Health.
NIHTurning Discovery Into Health

This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) 9000 Rockville Pike Bethesda MD 20892 301-496-4000 / TTY 301-402-9612

Deel deze op

Laden...

Andere nieuwsbrieven van Niaid.nih.gov

Find a plan for 2025! There is still time to enroll Niaid.nih.gov
28 minuten geleden
HRSA Supports Rural Health Care Niaid.nih.gov
Afgelopen vrijdag om 18:07
New savings available for 2025 health coverage Niaid.nih.gov
Afgelopen vrijdag om 15:44

Meer nieuwsbrieven van Niaid.nih.gov

Laden...

Temperature-Stable TB Vaccine Safe, Promp ts Immune Response in NIH-Supported Study

Deel deze op

Andere nieuwsbrieven van Niaid.nih.gov

Gerelateerde nieuwsbrieven